The Id proteins and basic helix-loop-helix (bHLH) proteins play major roles in specifying cell fate decisions in diverse biologic settings. A potential role for Id and TAL 7/EZA bHLH genes in hematopoiesis has been suggested by studies on immortalized cell lines. However, it is uncertain whether these observations reflect normal hematopoiesis. We have investigated the expression pattern of ld2 and TAL7/€2A genes in liquid suspension culture of purified hematopoietic progenitor cell (HPCs) undergoing erythroid or granulopoietic differentiation in the first culture week and maturation t o terminal cells in the second week. In quiescent, freshly purified HPCs, ld2 mRNA is detected by reverse transcriptase-polymerase chain reaction (RT-PCR), whereas TAL7 and E2A mRNAs are not. At the onset of erythroid differentiation, Id2 mRNA is downregulated. while E2A and TAL7 mRNAs are concomitantly upregulated: their expression is further increased at erythroblast level. Conversely, I d 2 is not downmodulated in granulopoietic culture, except for a late decline at day 10 t o 12, while TAL7 and E2A are only transiently induced in the first week of granulopoietic differentiation. The expression pattern of the TALl/EZA heterodimer, as evaluated by mobility shift assay, is consistent NTERACTING NETWORKS of Id proteins and basic helix-loop-helix (bHLH) proteins play a major role in specifying cell fate decisions in diverse biologic settings.'-4 The defining bHLH motif consists of a basic DNA binding domain and an adjacent protein-protein oligomerization domain.5 The bHLH systems bind DNA as obligate homoor heterodimers'.6 and act as transcription factors (TFs). Id proteins lack the basic region but retain the oligomerization domain; thus, they can counteract the activating function of bHLH systems via IdhHLH interaction and impede formation of bHLH/bHLH homo-or heterodimers; eg, Id proteins sequester the ubiquitous E protein and impede heterodimer formation with tissue-specific bHLH protein^.^ The IdhHLH network has been best defined in murine myogenic cell specification and differentiation. In these cells, the network includes multiple bHLH (ie, E proteins, myogenin/MyoD) and Id proteins: During terminal differentiation, Id is downregulated, and myogeninh4yoD is upregu- oligomer (cu-ld2) causes a significant dose-dependent increase of erythroid colony formation, whereas a-TAL7 induces a selective dose-related inhibitory effect on erythroid colonies, as compared with untreated or scrambled oligomer-treated control HPCs. Finally, murine and human glutathione-S-transferase (GST)-ld2 polypeptides compete the TALl/EZA-specific DNA binding activity when added to the nuclear extracts derived from erythroid culture cells, thus indicating biochemical and suggesting functional interaction of Id2 with the TALl/EZA complex. These novel observations indicate a coordinate expression and function of an inhibitory Id protein (Id21 and a stimulatory bHLH/bHLH heterodimer (TALl/EZA) in normal erythroid differentiation.
The Id proteins and basic helix-loop-helix (bHLH) proteins play major roles in specifying cell fate decisions in diverse biologic settings. A potential role for Id and TAL 7/EZA bHLH genes in hematopoiesis has been suggested by studies on immortalized cell lines. However, it is uncertain whether these observations reflect normal hematopoiesis. We have investigated the expression pattern of ld2 and TAL7/€2A genes in liquid suspension culture of purified hematopoietic progenitor cell (HPCs) undergoing erythroid or granulopoietic differentiation in the first culture week and maturation t o terminal cells in the second week. In quiescent, freshly purified HPCs, ld2 mRNA is detected by reverse transcriptase-polymerase chain reaction (RT-PCR), whereas TAL7 and E2A mRNAs are not. At the onset of erythroid differentiation, Id2 mRNA is downregulated. while E2A and TAL7 mRNAs are concomitantly upregulated: their expression is further increased at erythroblast level. Conversely, I d 2 is not downmodulated in granulopoietic culture, except for a late decline at day 10 t o 12, while TAL7 and E2A are only transiently induced in the first week of granulopoietic differentiation. The expression pattern of the TALl/EZA heterodimer, as evaluated by mobility shift assay, is consistent NTERACTING NETWORKS of Id proteins and basic helix-loop-helix (bHLH) proteins play a major role in specifying cell fate decisions in diverse biologic settings. '-4 The defining bHLH motif consists of a basic DNA binding domain and an adjacent protein-protein oligomerization domain. 5 The bHLH systems bind DNA as obligate homoor heterodimers'.6 and act as transcription factors (TFs). Id proteins lack the basic region but retain the oligomerization domain; thus, they can counteract the activating function of bHLH systems via IdhHLH interaction and impede formation of bHLH/bHLH homo-or heterodimers; eg, Id proteins sequester the ubiquitous E protein and impede heterodimer formation with tissue-specific bHLH protein^.^ The IdhHLH network has been best defined in murine myogenic cell specification and differentiation. In these cells, the network includes multiple bHLH (ie, E proteins, myogenin/MyoD) and Id proteins: During terminal differentiation, Id is downregulated, and myogeninh4yoD is upregu-with RT-PCR results (except for lower levels of the heterodimer in late erythroid maturation). TAL1 protein level, analyzed by Western blot, shows a pattern consistent with gelshift results. Functional experiments were performed on purified HPCs treated with phosphorothioate antisense oligodeoxynucleotides t o I d 2 or TAL7 mRNA. The results are strictly consistent with the expression studies: anti-ld2 oligomer (cu-ld2) causes a significant dose-dependent increase of erythroid colony formation, whereas a-TAL7 induces a selective dose-related inhibitory effect on erythroid colonies, as compared with untreated or scrambled oligomer-treated control HPCs. Finally, murine and human glutathione-S-transferase (GST)-ld2 polypeptides compete the TALl/EZA-specific DNA binding activity when added to the nuclear extracts derived from erythroid culture cells, thus indicating biochemical and suggesting functional interaction of Id2 with the TALl/EZA complex. These novel observations indicate a coordinate expression and function of an inhibitory Id protein (Id21 and a stimulatory bHLH/bHLH heterodimer (TALl/EZA) in normal erythroid differentiation. 0 7995 by The American Society of Hematology.
lated. In undifferentiated cells, Id sequesters the E protein from binding to MyoD, thus preventing the formation of an active transcriptional complex; after differentiation, downregulation of Id allows MyoD and E protein interaction to generate heterodimers activating muscle-specific genes. ',4 Hematopoiesis is a multistep cell proliferation and differentiation process that is sustained by a pool of hematopoietic stem cells (HSCs)."" HSCs are capable of extensive selfrenewal and feed into lineage-committed hematopoietic progenitor cells (HPCs). The HPCs are functionally defined as colony-forming (CFUs) or burst-forming units (BFUs), ie, HPCs of the erythroid (BFU-E, C m -E ) or granulomonocytic (CFU-GM) lineage and multipotent HPCs for the granulomonocytic, erythroid, and megakaryocytic series (CFU-GEMM). HPCs differentiate into morphologically recognizable precursors that mature to terminal elements circulating in peripheral blood (PB). HSCs and early HPCs are also present in PB mononuclear cells (PBMCs)."'."
The pivotal mechanisms underlying HPC lineage commitment and precursor maturation are seemingly mediated via lineage-restricted TFs: a major class of TFs in hematopoiesis may be represented by IdhHLH proteins.
This hypothesis has been tested in the murine myeloid precursor cell line 32D.I2 The undifferentiated cells express Id mRNA: after terminal granulocytic differentiation induced by granulocyte colony-stimulating factor (G-CSF), Id mRNA transiently decreases, with a concomitant rise of DNA-binding activity recognizing a canonical E-box motif in the muscle creatin kinase (MCK) promoter. Furthermore, Id1 transfection in murine erythroleukemia (MEL) cells inhibits terminal differentiation: this correlates with inhibition of MCK-E box-binding activity. ' erythroid differentiation; however, it is uncertain whether these studies reflect normal hematopoiesis.
At least three distinct genes encoding Id polypeptides have been identified in mammals: outside of the HLH domain, human Zdl and Id2 markedly differ, except for two homologous regions containing potential protein phosphorylation sites. 14 The TALIISCUTCLS gene, identified in a T-lymphocytic acute leukemia (T-ALL),'5"8 encodes a bHLH protein related to erythropoiesis. Indeed, (1) TALI expression is readily detectable in K562 and HEL erythroleukemic cell lines,l6.l9 as well as in human fetal liver" and murine yolk sac." (2) The transduced TALI gene enhances erythroid differentiation of MEL and K562 cell However, the TALl expressionifunction in normal adult erythropoiesis is still unknown.
In vitro studies indicate that the TALl protein interacts with class A bHLH proteins (E12 and E47) encoded by the E2A locus to form heterodimeric bHLH complexes (TAL1/ E12 and TALlE47) that bind E-box DNA sequence^.^^^^^ TALl and E2A also associate in leukemic T cells: these studies show that TALl does not form homodimers but requires in vivo heterologous interaction with E12 and E47." However, corresponding in vivo studies are not yet available.
Finally, recent observations indicate that Id2 protein competes with TALl for heterodimer formation with E2A in murine M l leukemic cell line induced to macrophage differentiati~n:'~ here again, it is uncertain whether these studies reflect normal hematopoiesis.
In an attempt to shed new light on these aspects, we have investigated the in vivo expressionifunction of Id2, TALI, and E2A genes in hematopoiesis, including (1) their expression in purified HPCs induced to specific erythroid or granulocytic differentiation in liquid suspension culture; (2) their functional role by treatment of HPCs undergoing erythroid or granulocytic differentiation with antisense oligodeoxynucleotides targeting Zd2 or TALI &A; and (3) the competing interaction between Id2 and TALlIE2A for sequencespecific DNA-binding activity.
MATERIALS AND METHODS

Hematopoietic Growth Factors and Culture Medium
Recombinant human interleukin-3 (rhIL-3) and granulocyte-macrophage colony-stimulating factor (rhGM-CSF; 1.7 to 2.5 x lo7 U/ mg) were supplied by Genetics Institute (Cambridge, MA); erythropoietin (Epo), by Amgen (Thousand Oaks, CA); and c-kit ligand (KL) by Immunex (Seattle, WA). Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY) was freshly prepared weekly.
Adult PB
Adult PB was obtained from 20-to 40-year-old healthy male donors after informed consent. Blood (450 mL 2 10%) was collected in preservative-free CPDA-1 anticoagulant (citrate-phosphate-dextrose-adenine). A buffy coat was obtained by centrifugation (Beckman J6M/E; Beckman Instruments, Palo Alto, CA; 1,400 rpm for 20 minutes at room temperature).
HPC PuriJication and Assay
Adult PB HPCs were purified according to a modification of the method reported by Gabbianelli et Residual cells were then counted and incubated again (1 hour at 4°C) with the same type of magnetic beads at a ratio of 10 beads per cell. Finally, the cells were counted again and incubated (30 minutes at 4°C) with magnetic beads coated with affinity-purified antimouse IgGl (Fc-specific, Dynabeads 110.04; Dynal) at a ratio of 10 beads per cell. Throughout this procedure the concentration of magnetic beads never exceeded 50 X 106/mL.
Step IIIP HPCs were routinely analyzed with a phycoerythrin (PE)-conjugated anti-CD34 MoAb (Becton-Dickinson). Cells were incubated for 30 minutes at 4°C in the presence of an appropriate amount of MoAb. After three washes with cold phosphate-buffered saline (PBS), cells were resuspended in PBS containing 2.5% formaldehyde and then analyzed by fluorescence-activated cell sorter (FACS; FACScan, Becton-Dickinson) for fluorescence intensity using a program for double immunofluorescence evaluation. At least 4,000 cells were analyzed for each determination.
The clonogenetic assay of purified HPCs in FCS' culture was performed as previously r e p~r t e d~~. '~ after addition of KL (10 ng/ mL), IL-3 (100 U), GM-CSF (10 ng), and Epo (3 U), unless otherwise indicated.
HPC Liquid Differentiation Culture
Step IIIP HPCs grown in FCS-liquid culture (5 X 104/mL in IMDM, supplemented as indicated below) were induced to specific erythroid or granulocytic differentiation by appropriate HGF combinations [saturating Epo and low IL-3/GM-CSF dosage (3 UlmL, 0.01 U, and 0.001 ng, respectively) for unilineage erythroid differentiation; saturating IL-3/GM-CSF dosage (100 U/mL and 10 ng, respectively) for selective granulocytic differentiation] as previously reported," in a fully humidified 5% COZ/5% OZ/90% N2 atmosphere.
FCS was substituted by BSA (fraction V, 10 mg/mL), pure human transferrin (0.7 mg/mL), human low-density lipoproteins (40 pg/ mL), insulin (10 pg/mL), sodium pyruvate mom), L-glutamine (2 X lo-' mom), rare inorganic elements'' supplemented with iron sulfate (4 X lo-' mom), and nucleosides (10 pg/mL of e a~h ) .~' Morphology analysis. Cells were harvested at different days, smeared on glass slides by cytospin centrifugation, and stained with May-Griinwald-Giemsa.
Membrane phenotype analysis. Cells were incubated for 30 minutes at 4°C with PE-or fluorescein isothiocyanate (F'ITC)-labeled anti-CD34 anti-glycophorin A (Immunotech, Marseille, France), anti-CD1 l b (Becton-Dickinson) MoAbs and analyzed as described above.
The clonogenetic assay of Step IIIP HPCs differentiating in ery-throid or granulopoietic culture was performed as described below after addition of the human growth factor (HGF) combination used in the corresponding liquid phase culture.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) mRNA Analysis
Methodology for semiquantitative RT-PCR analysis has been previously r e p~r t e d .~~. '~-~~ Briefly, total RNA, extracted by the guanidinium isothiocynate-CsC1 method from the same number of cells in the presence of 12 pg of Escherichia coli rRNA carrier, was quantitated by dot hybridization with a human rRNA probe.3' After densitometric analysis, the normalized amount of RNA was reverse-transcribed by Moloney murine leukemia virus reverse transcriptase (GIBCO-BRL, Gaithersburg, MD) with oligo (dT) as primer. The cDNAs were normalized by the P2-microglobulin gene (5' primer, 5'-AACCACGTGAC"TGTCACAGC-3'; 3' primer, 5"CTGCTC-AGATACATCAAACATG-3'; internal probe from 3 11 bp to 360 bp.36 Based on amplification dose-response results, P2-rnicroglobulin normalization was obtained by amplifying an aliquot of approximately 5 ng of RT-RNA by 20 PCR cycles; ie, the cycle number allowing a linear RT-RNA dose-response (denaturation at 95°C for 30 seconds, annealing at 52°C for 30 seconds, and extension at 72°C for 45 seconds) in a Perkin-Elmer Cetus (Nonvalk, CT) thermocycler.
To further insure semiquantitative RT-PCR assay for Id2, TALI, and E2A templates, several dilutions of RT-RNA from multiple HPC culture samples were amplified within the linear range by 40 PCR cycles: the dose-response curves consistently showed linearity for all points (see Results).
To evaluate the expression of ld2, TALI, and E2A genes, an aliquot of RT-RNA (approximately 20 ng) was amplified within the linear range by 40 PCR cycles. An aliquot of RNA (approximately 20 ng) of each sample and a mock reaction (negative controls) were amplified to exclude the presence of contaminant DNA. The amplification procedure involved denaturation at 95°C for 30 seconds, annealing at 54°C for ld2, at 58°C for TALI, and at 56°C for E2A; and extension at 72°C for 45 seconds for 40 PCR cycles.
RT-RNA from the K562 cell line or adult quiescent T lymphocytes, normalized together with RT-RNA from hematopoietic cells by the P2-microglobulin gene, was used as internal positive control. PCR products were analyzed by Southern blotting with an internal oligomer probe. Relative intensities of bands were quantified by scanning with a laser densitometer (Phosphorimager; Molecular Dynamics, Sunnyvale, CA).
The following 
Bacterial Expression of Murine and Human Glutathione-STransferase (GST)-Id2 Fusion Polypeptides
Plasmid pGEX-5X-3T (Pharmacia) was used for expression of wild-type GST protein. Plasmid Id2 PGEX-~X-~T, used for expression of the murine GST-Id2 fusion protein, was generated by inserting a 0.35-kb murine Id2 cDNA fragment39 into the BamHI/Sul I sites of pGEX-SX-3T. The human GST-Id2 fusion protein (pGSTld2) was obtained from Mark A. Israel (School of Medicine, University of California at San Francisco)."' Expression and purification of GST fusion proteins were performed as described previously." Rabbit Antisera TALI. Polyclonal antisera (no. 1080 and 370) were obtained against GST-fusion proteins containing the amino-terminal 121 residues and carboxy-terminal 94 residues, respectively.23
E2A. The GST-E2A fusion protein (E2A residues 2 17 to 37 I ) was used to produce polyclonal antisera.23
Electrophoretic Mobility Shijit Assay (EMSA) and Western Blot Analysis
The protein concentrations of all extracts were determined by the Bradford assay (Bio-Rad, Hertfordshire, UK). Each reaction contained, in 20 pL, 10 to 25 pg of nuclear extract, IO mmol/L HEPES (pH 7.9), 50 mmol/L KCI, 2 mmol/L Mg CCr, 4% Ficoll, 1 mmol/ L EDTA, I mmol/L dithiothreitol (DTT), 0.5 pg of poly (dI-dC), and 1 to 3 pmol of '*P-labeled, double-stranded oligonucleotide probe containing the preferred sequence for DNA-binding by TALI/ E2A heterodimers (top strand: ACCTGAACAGATGGTCGGCT)." After a 15-minute incubation at room temperature, the assay mixture was loaded onto a 15-cm 4% polyacrylamide gel containing 0 . 2 5~ TRIS-borateEDTA electrophoresis buffer and electrophoresed at 180 V for 2 to 3 hours at 4°C.
In some binding reactions, the nuclear extract was preincubated for 10 minutes at room temperature with 1 p L of TALl rabbit antiserum no. 370, the E2A antiserum, or the same amount of normal rabbit immunoglobulin. Where indicated, an approximately 100-fold molar excess of unlabeled competitor oligonucleotides was included in the binding reaction. Western blot analysis was performed with the anti-TALI (no. 1080) rabbit serum by enhanced chemiluminescence, according to the manufacturer's protocol (Amersham, Buckinghamshire, UK).
HPC Oligomer Treatment and Clonogenetic Assay
Oligomers. The following oligomers were used: Id2 antisense (ald2), 5'-CCTAACGGACCTCACGGGACTGAA-3' complementary to 24 nucleotides starting from the fourth codon Id2 mRNAL4; ald2 scrambled, 5' -CAACTAGCGTGAGAAGCCTGAACC -3' ; TALI antisense (aTALI), 5'-GCCTCGGCCGCGTCCCGT-3' complementary to 18 nucleotides starting from codon 18 of TALI mRNA3'; and aTALl scrambled, 5'-GCCGCCGTTCGCGTCCGC-3'.
Oligomer freatment.
Step IIIP cells were diluted in FCS-medium (see above) supplemented with HGFs (IL-3/GM-CSF/Epo; see Clonogenetic assay) in the presence or absence of antisense or randomly scrambled phosphorothioate oligomers at appropriate concentrations (25, 50, 100 pg/mL) and incubated overnight; cells were plated in clonogenetic culture in triplicate dishes (see be lo^).**.'^,^^,^'
Oligomer uptake. Fluoresceinated oligomers were obtained from National Biosciences (Plymouth, MN).
Step IIlP HPCs ( 5 X IO') were treated with 100 pg/mL scrambled or antisense oligomers overnight in F C S culture with standard HGFs (IL3IGM-CSFEpo; see Clonogenetic assay); cells were washed and analyzed by FACS.*X Clonogeneric ussay.
Step IIIP HPCs were seeded (2 X 10*/mL per dish, three plates per point) and cultured in 0.9% methylcellulose in IMDM supplemented with a-thioglycerol morn; Sigma) and different HGFs [IL-3 (100 U), GM-CSF (10 ng) 2 Epo (3 U), unless otherwise indicated] at 37°C in a 5% C02/5% 02/90% NZ humidified atmosphere.z6 FCS was substituted as indicated above for liquid suspension culture.
CFU-GEMM, BFU-E, and CFU-GM colonies were scored on day 16 to 18. In selected experiments, colonies were picked up, and the cell composition was analyzed as described.*'." 
RESULTS
HPC Purification and Unilineage Differentiation in Liquid Suspension Culture
In this experimental series, purified step IIIP cells comprised 85% to 95% CD34+ cells and 75% to 95% HPCs (BFU-E, CFU-GM, and CFU-GEMM), as assayed in clonogenetic culture after optimal HGF stimulus (saturating KLJ IL-3/GM-CSF/Epo dosage; Fig 1A) . It is noteworthy that the HPC recovery was markedly higher (45% mean value; Fig 1A) than reported by a previous methodology. 26 Step IIIP HPCs were induced to gradual unilineage erythroid or granulocytic differentiation up to terminal maturation by differential HGF stimulus; ie, saturating Epo and low IL-3/GM-CSF dosage, or saturating IL-3/GM-CSF level, respectively. These HGF combinations have been previously sed''^^' in unilineage liquid suspension culture of A series of controls insured a semiquantitative evaluation of mRNA levels (see Materials and Methods), including dose-response curves for the assayed templates (Fig 2A) . The expression of ld2, TALI, and E2A mRNA was evaluated in three separate RNA samples from three independent culture experiments. We observed a remarkably reproducible mRNA expression pattern: representative results are shown in Fig 2B. Id2 gene was present on day 0 quiescent HPCs. The expression level gradually decreased during initial erythroid differentiation to an undetectable level from day 5 through day 17, and was progressively reinduced in terminal maturation through day 10 to 17. Conversely, the Id2 mRNA level did not fluctuate during granulocytic differentiation/maturation, except for a transient drop at day 10 to 12.
TALI mRNA was not detected in quiescent HPCs. In the erythroid culture, TALI expression was induced through differentiation and initial maturation (from day 1 through 10) and then sharply increased in advanced maturation at day 12 to 14. In the granulopoietic system, expression was induced during the first week and drastically downmodulated during the second week.
The E2A mRNA pattern mimicks that of TALI. The E2A gene was not expressed in quiescent HPCs. In the erythroid culture, moderate expression was observed from day 7 through day 12 to 14. In the granulopoietic system E2A mRNA was detected at decreasing levels from day 1 through 7, followed by no expression through day 17.
EMSA of TALI/E2A Heterodimer in HPC Differentiation
To evaluate the DNA-binding activity of TALl in HPC erythroid and granulopoietic cultures, EMSA was performed with a radiolabeled oligonucleotide probe containing the TALl consensus E-box sequence.23
As shown in Fig 3A, incubation of this probe with the nuclear extract from Jurkat cells (lanes l through 6) generated several protein-DNA complexes (lane 2). Two of these complexes, indicated by dashes, deserve detailed analysis. We observed that (l) the high mobility complex was supershifted by preincubation with antiserum raised against the carboxy terminal 94 residues of TALl (lane 5), but not with the corresponding preimmune serum (lane 4); and (2) both the high and low mobility complexes were supershifted by preincubation with an anti-E2A rabbit serum (lane 3), but not with the corresponding preimmune serum (lane 2). In line with the results reported by Hsu et al,23 our observations confirm that the high mobility complex represents the E 2 N TALl heterodimer, while the low mobility one can be ascribed to the E2AE2A horn~dimer?~ as further indicated by in vitro studies2 ' We then assayed the nuclear extracts from day 7 erythroid culture ( Fig 3A) . The erythroid cells exhibit a band (lane 7) comigrating with the E2A/TAL1 complex in Jurkat cells (lane 6). This band is subtotally abrogated by incubation with the TALl consensus E-box oligonucleotide (lane 8). Furthermore, it is sharply supershifted by incubation with anti-TAL1 or anti-E2A sera (lanes 10 and 12, respectively), while it is not affected by the corresponding preimmune serum (lanes 9 and 11). We conclude that this band represents the E2A/TAL1 heterodimer in erythroid cells.
We then incubated the TALI consensus E-box sequence with equivalent amounts (10 pg) of nuclear extracts from erythroid and granulopoietic cultures (Fig 3B) : the E 2 N TALl heterodimer, not detected in quiescent HPCs at day 0 (lane 6), was present at days 7, 11, and 14 in the erythroid lineage (lanes 7, 8, and 9), but not in the granulopoietic series (lanes 10, 11, and 12). In other experiments, we also determined the presence of E2A/TAL1 heterodimers at days 7 and 12 (data not shown): we observed no difference when compared with days 7 and 11 (Fig 3B) . Thus, it is apparent that, in both erythroid and granulopoietic cultures, the kinetic pattern of E2A/TALl heterodimer roughly correlates with that of TALI and E2A mRNA, as evaluated by RT-PCR (at late erythroid culture times; however, the binding activity decreases, whereas the RNA expression is sustained).
The low mobility complex has a higher molecular weight in the erythroid lineage as compared with Jurkat cells (Fig  3A and B) . However, the low mobility band in erythroid cells is also diminished with the anti-TAL1 antibody, sug- 
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-253 bp 1 :9 1 :3 1:l Sample dilutions gesting that TALl is part of the complex (Fig 3B) . The possibility exists that, in the erythroid culture, TALlE2A can bind to other protein(s). Further studies are required to elucidate this aspect.
TALI Western Blot Assay
Western blot analysis was performed with equivalent amounts (13 pg) of nuclear extracts from day-0 HPCs and erythroid or granulopoietic culture at days 7 and 12 ( Fig  3C) . Immunoblotting was performed with rabbit antiserum no. 1080. TALl protein, not detected in day-0 HPCs, is selectively expressed in erythroid culture on day 7 and, at a lower level, on day 12.
Antisense Oligonucleotide Experiments
Three separate dose-response experiments were performed with phosphorothioate antisense oligomers to Id2 or TALI mRNA (a-Id2, a-TALI).
Step IIIP HPCs were incubated with 25, 50, and 100 pg a-Id2 or a-TALI oligomers, while control HPCs were either untreated or incubated with Jurkat cells Erythroid and granulopoietic cells Oligomer a-TALI induced a selective, dose-related inhibitory effect on erythroid colony formation as compared with untreated or scrambled oligomer-treated controls. This action was more pronounced when a-TALI was added not only on day 0, but also on day 3 (Fig 4B) : no statistically significant effect was observed when a-TALI was added on day 0 only (results not shown). Treatment with a-TALI did not significantly affect CFU-GM colony formation (Fig 4B) . Control RT-PCR experiments were performed to insure the specific suppression of TALI mRNA by a-TALI treatment. Thus, step IIIP cells were grown in liquid phase culture mimicking the methylcellulose culture conditions [ie, cells were treated with saturating IL-3/GM-CSF/Epo dosage and a-TALI at day 0 (100 pg) and day 3 (50 pg)]. At day 5 of culture, TALI mRNA was significantly reduced in a-TALI-treated cells, as compared with corresponding scrambled oligomertreated or untreated cells; 02-microglobulin mRNA levels were similar in all three groups (data not shown). Further control studies were performed to evaluate the oligomer uptake: greater than 90% of cells were labeled after overnight treatment with fluoresceinated a-TALI or scrambled oligomer. corresponding amounts of scrambled oligomers (Fig 4A and  B) . The clonogenetic assay of control, a-sense, or scrambled oligomer-treated HPCs was then performed in the presence of intermediate or saturating IL-3/GM-CSF dosage combined or not with intermediate or plateau Epo levels in experiments with a-Id2 or aTALI, respectively (Fig 4A and B) .
HPC Differentiation Culture
Treatment with a-Id2 caused a significant dose-dependent rise of BFU-E colonies, as compared with scrambled-treated or untreated controls. A modest, barely significant increase in CFU-GM colony number was observed only in the absence of Epo at the 100-pg a-Id2 dosage (Fig 4A) . Cdntrol RT-PCR experiments were performed to verify the specific suppression of Id2 mRNA by a-Id2 treatment. Thus, step IIlP cells were grown in liquid phase FCS-culture mimicking methylcellulose culture conditions (ie, cells were treated with intermediate IL-3/GM-CSF/Epo dosage and 100 pg aId2). After overnight culture, the Id2 mRNA level was 275% reduced in a-Id2-treated cells as compared with scrambled oligomer-treated and control ones, while 0 2 microglobulin mRNA level was similar in all three groups (results not shown). Similarly, Barone et a14' observed a decrease in murine Id2 mRNA levels in a-Id2-treated NIH3T3 fibroblasts. The reduction of Id2 mRNA is attributable to the RNase H activity on DNA-RNA hybrids"."; additionally, a-Id2Ad2 mRNA hybridization may inhibit Id2
Human and Murine GST-Id2 Polypeptides Compete With the TALI/E2A-Spec@c DNA-Binding Activity To test directly whether Id2 protein is capable of inhibiting specific DNA-binding by the TALlE2A heterodimers, murine and human GST-Id2 polypeptides were expressed in E coli and purified by affinity chromatography on glutathioneagarose beads. Murine and human GST-Id2 polypeptides, both containing the HLH region with 98% homology at the amino acid level, competed with the DNA-binding activity of the TALIE2A heterodimer when added to the nuclear extracts derived from day-7 erythroid culture cells (Fig 5) .
These results suggest that abrogation of the DNA binding by TALIE2A heterodimers in late erythroid maturation, as seen in Fig 3B, is likely caused by the reinduced expression of dominant negative Id2 protein.
DISCUSSION
The discrete molecular events underlying early hematopoiesis are still poorly understood, primarily due to the extreme rarity of HPCs and HSCs, which represent less than 1/0.01% and less than 0. I /O.OO 1 % of human bone marrowX early HPCs/HSCs be stringently purified and then cultured under conditions allowing a gradual, homogenous wave of differentiation specifically along one or more lineage(s).'" We have recently developed methodology for HPC purification and unilineage differentiation in liquid phase culture.
The original purification methodologyz6 has been recently improved to allow both stringent purification and abundant recovery of HPCs (CFU-GEMM, BFU-E, CFU-GM) from adult PB.".*' Several lines of evidence indicate that the puri- fied HPCs represent a homogenous population of highly undifferentiated HPCS.'"."~~'.~~ (1) They bear a highly undifferentiated membrane phenotype (ie, 80% to 90% HLA-DR+/ CD38+/CD45'""/CD45RA-, 40% c-kit+, less than 10% CD33+/1 la+/71high), which is similar to that of primitive bone marrow HPCS:"' (2) After differentiation in liquid suspension culture, they become CD34+/45high/33+/1 la+/ 7Ihigh; ie, they acquire the phenotype of intermediate-late bone marrow HPCS:~-" (3) They give rise to large colonies after optimal HGF stimulus (eg, approximately lo4 to lo5 cells per erythroid burst). (4) They are largely quiescent (1% to 2% tritiated thymidine suicide index). Furthermore, we have developed an FCS-liquid suspension culture for gradual differentiation of the purified step IIIP early HPCs along the erythroid or granulopoietic lineage (the latter culture system comprises 5 5 % to 10% monocytes at late culture These culture systems allow sequential collection and molecular analysis of discrete subsets of HPCs and hematopoietic precursors at a homogenous stage of differentiation specifically along a particular lineage." These experimental tools have been used to evaluate the expressiordfunction of Id2, TALI, and E2A genes in hematopoietic differentiation. Lane No.
Nuclear Extract Human GST-Id2
Murine GST-Id2 GST TALl /E2* expression pattern. Both genes, while silent in quiescent HPCs, are expressed in the erythropoietic pathway, particularly at advanced maturation stages. In granulopoietic differentiation, their expression is initially induced but then abrogated at the early maturation stage.
The expression pattern of the heterodimeric TALlE2A protein complex is basically in line with that of TALI and EZA mRNA. The TALlE2A heterodimer is absent in quiescent HPCs, present throughout erythroid maturation, and not detected in granulopoietic maturation. Similarly, TALl protein is detected by Western blot assay in erythroid but not granulopoietic culture.
The accumulation of TALI mRNA at the late erythroid maturation stage (ie, day 10 to 12) does not reflect a comparable accumulation of TALl protein, as evaluated by Western blot. This difference may be hypothetically ascribed to a regulatory mechanism hindering TALI mRNA translation in terminal erythroid maturation: further studies are required to elucidate this aspect.
It is noteworthy that TALI expression data are consistent with the functional results. Thus, a-TALI oligomer selectively causes a marked decrease of TALI mRNA level and a dose-related inhibitory effect on erythroid colony formation: the inhibition is dependent on repeated addition' of the oligomer (at days 0 and 3), thus indicating that TALl is functionally required after initiation of the erythroid differentiation program. The blockade of erythroid differentiation induced by a-TALI is only partial: this indicates that the suppression of TALl expression induced by a-TALI was not complete, and/or other erythroid TFs cooperate with TALl to induce erythroid differentiation in relatively advanced stages (see below).
Studies on erythroleukemic cell line^'^^^' and erythroid ontogenetic de~elopment'~.~" have suggested but not proven a possible role for TALl in erythropoiesis. Our results provide novel in vivo evidence on the expression and role of TALI and TALlE2A complex in normal adult erythroid progenitor differentiation. The mechanism of TALl function in erythropoiesis deserves discussion. In differentiating purified HPCs, the expression pattern of TALI gene is remarkably similar to that of GATA-I'*: both patterns are characterized by cell cycledependent initiation and lineage-dependent abrogation in the granulopoietic series. In this regard, several lines of evidence suggest a close functional relationship between TALl and GATA-I genes. TALI is expressed in erythroid, mast, and megakaryocytic cell lines"7,s3-a profile remarkably similar to that of GATA-I. Furthermore, TALI may be a target for GATA-I in that the TALl proximal promoter displays a GATA motif that binds GATA-I with high affinity, GATA-I is required for full TALI promoter activity in transfection experiments, and the proximal TALI promoter mediates reporter transactivation by overexpressed GATA-1 protein.'"."~ A key mechanism in erythroid differentiation may be represented by GATA-l activation of the TALl gene via the GATA motif in the TALI proximal promoter: this would in turn lead to TALlE2A heterodimer formation and activation of erythroid-specific genes via interaction with E-box motifs in their promoters. In this regard, a survey of the nucleotide data base showed possible TALlE2A binding sites associated with a number of candidate erythroid target genes: eg, in the hypersensitivity site 2 of the &globin locus control region (CCCAGATGTT), near the 3"enhancer of the human y-globin gene (AACAGATGTT), and in the erythroid promoters of the carbonic anhydrase II ("CATATGTT), band 3 (TCCAGATGTG), and GATA-I (ATCATATGTA) genes."
The relationship between the Id2 and TALIE2A expression/function in differentiating HPCs is of interest. As previously mentioned, in the murine 32D and MEL cell lines, induction of granulopoietic and erythroid differentiation is coupled with downmodulation of Id and upmodulation of an E-box-binding activity.'*." Furthermore, Id2 protein competes with TALI for heterodimer formation with E2A in murine M 1 leukemic cell line induced to macrophage differentiation." However, these studies on immortalized murine cell lines do not elucidate the expressiodfunction of Id protein in normal human hematopoiesis.
We observed that in HPC erythroid differentiation the Id2 expression/function pattern mirrors that of TALl and E2A. Indeed, Id2 mRNA is present in quiescent HPCs, but is gradually abrogated in early erythropoiesis up to the advanced maturation stage. Furthermore, a d d 2 treatment selectively induced a marked decrease of Id2 mRNA level and an enhanced erythroid colony formation. [Id1 and Id3 mRNAs are barely or not expressed in HPC erythroid and granulopoietic differentiation (data not shown).] More importantly, murine and human GST-Id2 polypeptides competed with the specific DNA-binding activity of the TALI/ E2A heterodimer when added to nuclear extracts from day-7 erythroid culture cells. Thus, these experiments suggest that abrogation of the TALlE2A-specific DNA-binding activity in late erythroid maturation is likely caused by the reinduced expression of dominant negative Id2 protein.
Collectively, these novel results suggest that in the normal adult erythropoietic system downmodulation of Id2 allows the TALl and E2A protein interaction to generate heterodimers activating erythroid-specific genes. In the final erythroid maturation stage, Id2 upmodulation may hamper TALlE2A heterodimer formation, thus leading to terminal suppression of erythroid specific genes.
Our observations indicate a coordinate expression and function of an inhibitory Id protein and a stimulatory bHLH heterodimer (TALlE2A) in normal adult erythroid differentiation. Similar inhibitory/stimulatory Id/bHLH protein mechanisms may operate in other, particularly granulopoietic," hematopoietic lineages.
